COVID-19 latest NIH updates

Emergency Funding for SARS-CoV-2 and COVID-19

NIAID issued two Funding Opportunity Announcement (FOA) to provide an expedited funding mechanism for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19):

Notice of Information: Contributing to the Global COVID-19 Crisis Response by Allowing Some NCI-supported Projects to be Redirected to COVID-19-related Research During the Crisis

NCI anticipates that in infrequent cases, NCI-funded investigators will have novel insights and research proposals of immediate relevance to SARS-CoV-2 and COVID-19. In those cases, but only for the duration of the present crisis, NCI would consider requests from its funded grantees and cooperative agreement awardees to engage in limited COVID-19 related research using part of their existing NCI-funded resources under the following conditions:

  • Any proposed COVID-19 projects would have to be novel, innovative, compelling, and scientifically meritorious. Projects should have cancer relevance and the potential for high impact.
  • Proposed projects should not duplicate other efforts or be simple extensions or modifications of ongoing research.
  • Proposed projects must be able to start immediately and be time limited, not to exceed 1 year.
  • If the proposed research requires access to laboratories and facilities currently not available, the sponsoring institution must provide explicit concurrence that those facilities would be made available for the project.
  • The investigator must have the resource capacity within the existing NCI grant to pursue the project.

More information can be found on the website.